Full Description
Over the course of the last decade, the treatment of gynaecologic cancer has evolved quite rapidly. New scientific and clinical advances have modified the standard of care and led to improved patient outcomes. At the same time, the treatment of gynaecologic cancer has become increasingly complex, requiring the comprehensive review and assessment of multiple issues including genetics, radiology, surgery, molecular diagnostics, chemotherapy, and more. As a result, the harmony and open communication between these specialties facilitated by a multidisciplinary team approach are crucial in providing the best care to patients and ensuring successful treatment.
Gynecologic Cancers: A Multidisciplinary Approach to Diagnosis and Management, written by a multidisciplinary team of authors representing a range of disciplines, is a valuable resource for physicians, fellows, nurses, physician assistants, physical therapists, and all health care providers involved in the treatment of gynaecologic cancer. Gynecologic Cancers: A Multidisciplinary Approach to Diagnosis and Management summarises the state-of-the-art issues related to the treatment of gynaecologic cancer and describes an approach for optimal multidisciplinary care for women who have been diagnosed with or who are at higher risk to develop gynaecologic cancer.
About the Series: The Current Multidisciplinary Oncology series, edited by Charles R. Thomas, consolidates and integrates the varied aspects of multidisciplinary care for major topics in oncology, including breast, lung, prostrate, head and neck and more. The volumes in the Current Multidisciplinary Oncology series represent all related topic areas, including oncology, radiation oncology, pain, pathology, imaging, psychological support and the primary disease. In addition, each volume includes a chapter focusing on special populations and the disease's impact / difference on them, and discussion of future directions and quality of life issues. In addition each volume has a chapter written by a private practice oncologist.
Contents
A. Importance of the Multidisciplinary Approach to Gynecologic Cancers; B. Cervical Cancer and Precancerous Lesions: 1. The Biology of Human Papillomavirus and the Etiology of Female Genital Tract Cancers; 2. Cervical Cancer Prevention: HPV Vaccines; 3. Cervical Cancer Prevention: Screening and Diagnostic Accuracy; 4. Management of Cervical Dysplasia and Precancerous Lesions; 5. Management of Recurrent Cervical Cancer; 6. Multimodality Treatment of Rare Cervical Cancer; 7. Principles of Radiation Therapy for Cervical Cancer; C. Multimodality Approach to Cancer of the Uterine Corpus: 8. Surgical-Pathologic Features of Uterine Cancers; 9. Multidisciplinary Treatment of Endometriod Uterine Carcinoma; 10. Multidisciplinary Management of Serous Carcinoma of the Endometrium; 11. Multidisciplinary Approach to Diagnosis and Treatment of Uterine Sarcomas; D. Epithelial Ovarian Cancer: 12. Molecular Pathogenesis of Ovarian Cancer; 13. Current Status of Inherited Predisposition to Ovarian Cancer: Lessons From Familial Ovarian Cancer Registries in the UK and USA; 14. Surgical Management of Ovarian Cancer; 15. Recurrent Ovarian Cancer: Approach to Diagnosis and Treatment; 16. Multidisciplinary Palliative Care; E. Borderline Ovarian Tumors: 17. A Multidisciplinary Approach to Diagnosis and Treatment of Borderline Ovarian Tumors; 18. Germ Cell Tumors of the Ovary: Multidisciplinary Approach to Diagnosis and Treatment; 19. Non-Epithelial Ovarian Cancer; F. Cancer of the Vulva; 20. Multidisciplinary Approach to Diagnosis and Treatment of Early Cancer; 21. The Role of Sentinel Lymph Node Mapping; G. Gestational Trophoblastic Disease: 22. Pathogenesis and Multidisciplinary Approach to Evaluation, Diagnosis and Treatment of Molar Gestation; 23. Placental Site Trophoblastic Tumor; H. Future Directions in the Treatment of Gynecologic Cancers: 24. Laparoscopy and Robotic-Assisted Surgery in Gynecologic Oncology; 25. Innovations in Radiotherapy of Gynecologic Cancers; 26. PARP Inhibitors in Gynecologic Malignancies; 27. Hormonal Treatment in Gynecologic Oncology; 28. Genomic an Proteomic Biomarkers for Ovarian Cancer Screening, Prognosis, and Individualization of Chemotherapy; 29. Incorporating Translational Research into Treatment of Gynecologic Cancers while Balancing the Focus of Personalized Medicine; 30. Integrative Medicine in Gynecologic Oncology.
